VivoSeq
Other

Dental Implant

1

Pipeline Programs

9

Active Trials

3

Companies Involved

Dental Implant is an early-stage landscape with 1 program across 3 companies. The most active players are OraPharma, Zeliha Başak Çakır Erdil, International Dental Contiuing Education.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

95/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

38

clinical trials

Completed19 · 50%
Unknown status9 · 24%
Not yet recruiting4 · 11%
Recruiting3 · 8%
Active, not recruiting2 · 5%
Withdrawn1 · 3%

Trial Activity

38 trials

Impact of Biological Factors on Dental Implant
Not yet recruiting··N/A·NCT06037070·10 enrolled
Influence of Human Platelet Derivatives on Dental Implant
Not yet recruiting··N/A·NCT06044246·30 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)